Related Experiment Video
Updated: Jun 8, 2026
A Simplified Model for Heterotopic Heart Valve Transplantation in Rodents
Published on: September 21, 2021
[Current outcomes and future perspectives of pediatric heart transplantation]
1Department of Cardiovascular Surgery, Chiba University Graduate School of Medicine, Chiba, Japan.
Insights
Pediatric heart transplantation faces unique challenges like congenital heart disease and donor shortages. Advances have improved early survival, but long-term graft issues and donor availability remain critical areas for research.
Area of Science:
- Cardiovascular Surgery
- Pediatric Cardiology
- Transplantation Immunology
Context:
- Pediatric heart transplantation presents distinct obstacles compared to adult procedures.
- Key challenges include anatomical variations in congenital heart disease, limited pediatric mechanical circulatory support, and immature immune systems.
- Somatic growth considerations are also unique to the pediatric population.
Purpose:
- To review the unique challenges and recent advancements in pediatric heart transplantation.
- To highlight areas requiring further investigation for improved patient outcomes.
Summary:
- Significant improvements in early survival have been observed over the past two decades.
- The primary obstacle remains a critical shortage of donor hearts, particularly for infants.
- Graft coronary artery vasculopathy is a major limitation to long-term survival, though less prevalent than in adults.
Impact:
- Research into ABO-incompatible and after-cardiac-death donors may expand the organ pool.
- Addressing donor organ scarcity and graft vasculopathy is crucial for advancing pediatric heart transplantation.
- Development of pediatric mechanical circulatory support devices is essential for pre-transplantation management.
Abstract:
Pediatric heart transplantation involves many challenges not frequently encountered in the adult population. Several unique issues include the large variation in cardiac configuration in congenital heart disease, limited availability of mechanical circulatory assist devices, immature immune responses, and consideration of somatic growth. Nevertheless, significant improvement in survival outcomes has been achieved in the last two decades, mainly from the decreased mortality early after transplantation. A severe shortage of donor hearts is the most serious problem, especially in infants who cannot be supported by assist devices. The use of ABO-incompatible or after-cardiac-death donors is under investigation to maximize the available organ pool. Long-term survival is still limited mainly by graft coronary artery vasculopathy, although its incidence is less than in the adult population. Further efforts are required to increase available donors, overcome graft coronary artery vasculopathy, and improve pretransplantation management including the development of pediatric mechanical circulatory support devices.
Related Concept Videos
01:24Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
01:28Kidney Transplant I: Introduction
01:29Cardiomyopathy V: Interprofessional Care